Emergence and Expansion of a Carbapenem-Resistant <named-content content-type='genus-species'>Pseudomonas aeruginosa</named-content> Clone Are Associated with Plasmid-Borne <italic toggle='yes'>bla</italic>_KPC-2 and Virulence-Related Genes

Yanyan Hu,Congcong Liu,Qi Wang,Yu Zeng,Qiaoling Sun,Li-xin Shu,Jiayue Lu,J. Cai,Shaolin Wang,Rong Zhang,Zuowei Wuc

2021-01-01

Abstract:Pseudomonas aeruginosa is a major opportunistic pathogen and one of the leading bacterial species causing health care-associated infections. Carbapenems are the most effective antimicrobial agents for the treatment of severe infections caused by P. aeruginosa. However, our recent surveillance demonstrated that the prevalence of carbapenem-resistant P. aeruginosa (CRPA) reached 38.67% in Zhejiang, China. By analyzing CRPA isolates collected from patients from 2006 to 2018, we found that 33% of CRPA isolates carried the gene blaKPC-2, which conferred high-level resistance to carbapenems and other b-lactams. In particular, a CRPA clone, ST463 (sequence type 463), emerged and has become the predominant CRPA clone among the population. Genome sequencing demonstrated that ST463 expansion was associated with plasmid-borne blaKPC-2. The mobile element flanking blaKPC-2, the type IV secretion system, and the successful expansion of clone ST463 might have further favored blaKPC-2 spread in P. aeruginosa. Molecular clock analysis dated the emergence of clone ST463 to around 2007. Genome-wide association analysis showed that 567 genes were associated with clone ST463, including several known virulence genes related to the biosynthesis of lipooligosaccharide (LOS) O-antigens and exotoxin. These findings indicate that ST463 is expanding with plasmid-borne blaKPC-2 and virulence-related genes in nosocomial infections, and close surveillance should be undertaken in the future. IMPORTANCE Health care-associated infections, also known as nosocomial infections, are the most frequent adverse events in health care delivery worldwide, causing high rates of morbidity and mortality and high health care costs. Pseudomonas aeruginosa is one of the leading bacterial species causing health care-associated infections. Carbapenems are the most effective antimicrobial agents for the treatment of its severe infections. However, the prevalence of carbapenem-resistant P. aeruginosa (CRPA) has been increasing rapidly in recent years, and our surveillance demonstrated that the prevalence of CRPA reached 38.67% in Zhejiang, China. Genome sequencing of CRPA isolates over a decade showed that a CRPA clone (ST463) emerged recently. The clone is highly resistant to b-lactams, including carbapenems, and fluoroquinolones. Genome-wide association analysis showed that the clone expanded with virulence-related genes and the plasmid-borne carbapenem-resistant gene blaKPC-2. These findings are of significant public health importance, as the information will facilitate the control and minimization of CRPA nosocomial infections.